Carilex Medical Group

What Carilex Medical Group does

Carilex Medical Group is a Frankfurt, Germany-based private medical device company operating in the advanced wound care market. Founded in 1985, the company focuses specifically on pressure ulcer (pressure injury) prevention and treatment — a therapeutic niche serving hospitals, long-term care facilities, and home-care settings where immobilized patients face elevated risk. Its product portfolio centers on pressure-redistributing support systems — therapeutic mattresses, overlays, and integrated pump/control units — used as both preventive and interventional devices within clinical pressure-injury protocols. The corporate website is carilexmedical.com.

The firm is structured as a privately held, for-profit entity with a reported headcount of 51–100 employees, placing it in the mid-sized specialty manufacturer tier of the European medical device industry. The implied business model is B2B sale of medical capital equipment and recurring consumables to healthcare providers; however, the source data does not disclose pricing models, distribution channels (direct vs. third-party distributor), geographic revenue mix, regulatory clearances (CE-mark, FDA 510(k)), reimbursement coding, or specific contract structures. The publicly accessible company website currently displays only a verification/loading page, which materially limits the ability to confirm current product specifications, certifications, or active commercial programs from secondary observation.

Leadership disclosed in the source material consists of Andy Cheng as Chairman; no additional executive team, board composition, or investor roster is provided. There is no information in the input data on funding rounds, M&A activity, strategic partnerships, recent product launches, regulatory actions, or named customers, which constrains the ability to triangulate revenue, growth trajectory, or commercial momentum. All forward-looking analysis should accordingly be treated as low-confidence pending access to primary-source corporate disclosure (audited financials, distributor filings, CE/FDA databases, trade-show announcements, or registry filings).

Name

Carilex Medical Group

Website

https://carilexmedical.com

Company type

Private

Founded year

1985

Headcount range

51–100 employees

Short description

Carilex Medical Group is a Frankfurt, Germany-based private medical device company, founded in 1985, that develops pressure ulcer prevention and treatment technology for the advanced wound care market, serving hospitals, long-term care, and home-care providers with 51–100 employees.

Ownership category

akta.pro rank

Product category

Wound Care Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Wound Care & Ulcer Management (HLAKACAN)

akta.pro secondary industry

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

• Pressure ulcer prevention
• Wound care devices
• Therapeutic support surfaces
• Pressure injury treatment
• Medical mattress systems

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Core offering

Carilex Medical Group operates in the wound care market, producing technology for the prevention and treatment of pressure ulcers (pressure injuries). The company manufactures therapeutic support surface systems and related medical devices designed to help healthcare providers manage and prevent pressure-related skin and tissue damage in patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Pressure Ulcer Prevention and Treatment Technology

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• Hillrom (now part of Baxter): Hillrom's Centrella and Progressa beds and P500/P2500 therapeutic surfaces directly compete with Carilex in pressure-injury prevention and treatment systems for acute and long-term care. Both target hospital and post-acute buyers with alternating-pressure and low-air-loss technology.
• Arjo: Arjo's Auralis, Citadel, and Enterprise therapeutic support systems directly overlap with Carilex's alternating-pressure mattress portfolio for pressure ulcer prevention in hospitals and care facilities. Both companies compete in the same VTE/pressure-injury prevention category.
• Linet Group: Linet's Eleganza and Multicare smart-bed platforms integrate pressure-injury prevention surfaces comparable to Carilex's offerings. Both companies serve European hospitals with a focus on therapeutic support surfaces for pressure ulcer prevention.
• Talley Group: Talley Group manufactures the Quattro and Premier alternating-pressure mattress systems for pressure ulcer prevention, directly competing with Carilex in UK/EU acute-care and community-care settings.
• Invacare: Invacare offers the microAir and MA50/MA95 alternating-pressure and low-air-loss mattress lines targeting the same pressure-injury prevention use case as Carilex, with overlap in long-term care, home care, and skilled-nursing facilities.
• Joerns Healthcare: Joerns Healthcare's Dolphin, Aurum, and WoundPro portfolios include therapeutic support surfaces for pressure injury treatment and prevention. Both companies serve the wound-care continuum with overlapping surface technologies.
• Huntleigh Healthcare: Huntleigh's Nimbus and Breeze alternating-pressure mattress systems compete head-to-head with Carilex in hospital and community pressure-injury prevention, with particular overlap in EU and UK NHS procurement channels.

Broad incumbents

• Stryker: Stryker's Medical division includes the InTouch and iBed platforms with integrated pressure-redistribution surfaces, competing with Carilex in acute care. As a broad medtech incumbent, Stryker bundles therapeutic surfaces with beds and connected-care software at a larger scale.
• Mölnlycke Health Care: Mölnlycke is a broad wound-care incumbent whose Mepilex and Avance negative-pressure wound therapy products sit adjacent to Carilex's pressure-injury prevention focus. Both target hospital and community wound-care buyers with overlapping clinical audiences.
• Drive DeVilbiss Healthcare: Drive DeVilbiss distributes therapeutic support surfaces including the Balanced Aire and Gravity series, directly competing with Carilex in pressure-redistribution products across long-term care and home-care channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/CarilexMedical
• Facebookfacebook.com/carilexmedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carilex Medical Group